Healthcare & Life Sciences Industry Updates

Google News – FDA (biotech/pharma) External News

Korea’s HLB fails to win FDA approval on liver cancer drug for 3rd time; stocks hit 9-month low - The Korea Economic Daily Global Edition

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA criticizes Lundbeck: Websites are “false or misleading” - medwatch.com

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA Begins Pilot To Incentivize US-Based Pharma Manufacturing - DCAT Value Chain Insights

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

UroGen Pharma (URGN) Is Up 5.8% After FDA Clears IND For UGN-501 Phase 1 Trial - simplywall.st

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector - Fierce Pharma

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

Apnimed files for IPO as FDA reviews its sleep apnea drug - Endpoints News

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA thumbs up for Sanofi’s subcutaneous Sarclisa Escena - The Pharma Letter

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

Whistleblower takes on health insurance and FDA commissioner candidates - STAT

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

Pfizer, Astellas Expand PADCEV-Keytruda Label With FDA Nod In Bladder Cancer - Benzinga

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA Regulatory Overhaul: New Rule to Boost Domestic Pharma and Track Foreign Drug Origins - News and Statistics - IndexBox

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

OKYO Pharma advances toward Phase 3 FDA trial - ICYMI - Proactive Investors

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA decision on HLB liver cancer combo delayed, again, over Hengrui plant issues - koreabiomed.com

news.google.com · 11 Jul 2026

Google News – FDA (biotech/pharma) External News

Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine - Fierce Pharma

news.google.com · 11 Jul 2026

Google News – Clinical Trials External News

Non-profit DNDi preps phase 3 trials for dengue antibody - pharmaphorum

news.google.com · 11 Jul 2026

Google News – Clinical Trials External News

First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients - Medical Xpress

news.google.com · 11 Jul 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Why healthcare providers are sidelining employees amid coronavirus pandemic

For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions

New Alzheimer’s blood test may tell when symptoms are around the corner

4 takeaways from MDUFA VI draft agreement

J&J wins FDA approval for dual-energy ablation catheter

Physicians’ wearable data use hampered by reimbursement, workflow barriers: survey

Vacancy: National Consultant (NO C) to strengthen maternal and newborn health systems.

Stanford Health Care Tri-Valley launches hospital expansion - Stanford Medicine

HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas - UT Southwestern Medical

Hospital and health system leaders participate in Healthcare of Tomorrow Conference - American Hospital Association

HCA Healthcare hospitals earn 26 Press Ganey Human Experience Awards for patient experience - HCA Healthcare Today

CEO Nancy Brown named to Becker’s Hospital Review’s 2026 “Great Leaders in Healthcare” list - www.heart.org

Enhancing healthcare workers’ safety and well-being through a comprehensive qualitative analysis across hospital settings - Nature

Providers race to scale hospital-at-home before reimbursement changes - Modern Healthcare

One or Two Health Systems Controlled the Entire Market for Inpatient Hospital Care in Nearly Half of Metropolitan Areas in 2024 - KFF

How the hospital-at-home program offers alternative care as demand surges - investigatetv.com

Layoffs, closures tracker: Adventist Health cuts 132 jobs - Modern Healthcare

Experts: Cuts to federal student loans could hurt first generation students, healthcare industry - MPR News

Korea’s HLB fails to win FDA approval on liver cancer drug for 3rd time; stocks hit 9-month low - The Korea Economic Daily Global Edition

FDA criticizes Lundbeck: Websites are “false or misleading” - medwatch.com

FDA Begins Pilot To Incentivize US-Based Pharma Manufacturing - DCAT Value Chain Insights

UroGen Pharma (URGN) Is Up 5.8% After FDA Clears IND For UGN-501 Phase 1 Trial - simplywall.st

Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector - Fierce Pharma

Apnimed files for IPO as FDA reviews its sleep apnea drug - Endpoints News

FDA thumbs up for Sanofi’s subcutaneous Sarclisa Escena - The Pharma Letter

Whistleblower takes on health insurance and FDA commissioner candidates - STAT

Pfizer, Astellas Expand PADCEV-Keytruda Label With FDA Nod In Bladder Cancer - Benzinga

FDA Regulatory Overhaul: New Rule to Boost Domestic Pharma and Track Foreign Drug Origins - News and Statistics - IndexBox

OKYO Pharma advances toward Phase 3 FDA trial - ICYMI - Proactive Investors

FDA decision on HLB liver cancer combo delayed, again, over Hengrui plant issues - koreabiomed.com

Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine - Fierce Pharma

Non-profit DNDi preps phase 3 trials for dengue antibody - pharmaphorum

First-in-human immunotherapy more than doubles progression-free survival in glioblastoma patients - Medical Xpress